Literature DB >> 7506262

Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells.

S M Hwang1, C A Lopez, D E Heck, C R Gardner, D L Laskin, J D Laskin, D T Denhardt.   

Abstract

We report that osteopontin (OPN), a secreted, Arg-Gly-Asp-containing phosphoprotein expressed at high levels in the kidney, suppresses nitric oxide (NO) synthesis induced by the inflammatory mediators gamma-interferon and lipopolysaccharide in primary mouse kidney proximal tubule epithelial cells. Northern blot and immunofluorescence analyses of inducible nitric oxide synthase (iNOS) expression revealed that the inflammatory mediators increased iNOS mRNA and protein levels. Recombinant human OPN (purified from both mammalian cells and from Escherichia coli) inhibited this response by a process that was blocked by anti-OPN antiserum and by the peptide GRGDS, but not GRGES. The data suggest that inhibition of NO synthesis by OPN in these kidney cells is mediated by an integrin, possibly the alpha v beta 3 integrin, which is known to be an OPN receptor. NO is believed to control blood flow through the glomerulus, regulating salt and water balance, and to be important as a defense against tumor cells and infecting microorganisms. The ability of OPN to inhibit the induction of iNOS suggests that OPN may be an important regulator of the NO signaling pathway and NO-mediated cytotoxic processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506262

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

2.  Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Authors:  Julie L Chan; Thomas M Reeves; Linda L Phillips
Journal:  Exp Neurol       Date:  2014-08-21       Impact factor: 5.330

3.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

4.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo.

Authors:  C M Giachelli; D Lombardi; R J Johnson; C E Murry; M Almeida
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice.

Authors:  Bihua Wu; Qingyi Ma; Hidenori Suzuki; Chunhua Chen; Wenwu Liu; Jiping Tang; John Zhang
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

6.  Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.

Authors:  H Yoshitake; S R Rittling; D T Denhardt; M Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 7.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

8.  Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period.

Authors:  T Nagatomo; S Ohga; H Takada; A Nomura; S Hikino; M Imura; K Ohshima; T Hara
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

9.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

10.  Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production.

Authors:  Kathryn X Wang; Yufang Shi; David T Denhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.